TRUST IN THE DEPTH OF OUR SUPPORT
Our priority is to support you
and your patients
with ongoing educational events
and patient support materials
Supporting you and your patients
Helps you deliver the best patient care with HCP educational and support services, initiatives and innovations
Go further with patient support
Optimising prostate cancer
patient care through patient engagement, education, and support
Unlock the full potential of life
Find out more about
our evolving
support in urology
HCP, healthcare professional.
Contact us for more information
Recordati helps you to deliver the best patient care
With educational and support services, initiatives, and innovations
UROLOGY
As a leader in the treatment of urology, Recordati helps to advance your development with access to exclusive events, bespoke learning experiences and essential resources.
Click here or scan the QR code to visit recordati-urology.info for upcoming educational events, congresses and comprehensive resources
Going further for your patients
When men are diagnosed with prostate cancer, they often feel a loss of identity, distress and the need for support
Recordati offer information, advice & resources to help your patients diagnosed with and treated for prostate cancer
Here to support you in urology, continuing to expand and providing therapeutic solutions for:
Prostate cancer
Benign prostatic hyperplasia
Over-active bladder
Infection-related diseases
Premature ejaculation & erectile dysfunction
Product availability may differ by country. Please contact your local Recordati representative to find out more.
References
- ELIGARD SmPC. Latest version.
This website is intended for healthcare professionals only.
ELIGARD (leuprorelin acetate) is indicated for the treatment of hormone dependent
advanced prostate cancer and for the treatment of high-risk localised and locally advanced
hormone dependent prostate cancer in combination with radiotherapy.1
GL-ELIGA-0020 | August 2025 © 2025 Recordati